Skip to content
news
WIKENFARMA: NON MIGLIORE… DIVERSA!
Quattro pilastri fondamentali che differenziano l’azienda sul panorama internazionale
Index
“Cogito ergo sum,” said the philosopher Descartes centuries ago: famous for his rationalistic conception of reality that is based on facts and evidence. Thinking is what makes every individual and every reality, large or small, unique and different, and it is precisely uniqueness that remains etched in the minds of the community: being DIFFERENT and acting according to principles based on real observations and data is a strength that distinguishes a company from the infinity of alternatives on the now vast market.
Ma cosa rende un’azienda davvero unica e DIVERSA sul panorama nazionale e internazionale?
The constant desire for improvement and growth has led Wikenfarma to establish itself as a benchmark in trichology and to distinguish itself from competitors thanks to its disease-, age- and gender-specific products-all thanks to the constant support of the medical profession and experts in the clinical field. The company’s goal has always been to be able to provide tailor-made therapy to the patient, so as to give concrete benefit to as many people as possible.
Having clear in mind what makes this reality different is a very important starting point: in fact, Wikenfarma bases its entire philosophy and approach on 4 real “pillars of diversity.”
1. Metabolic approach
The uniqueness of Wikenfarma (with its RestaX and TriVis brands in particular) lies not only in the products and their disease-, age-, and gender-specific formulations, but finds its deepest meaning in the logics that lead to the formulation of the products: these differ first and foremost in their approach, as they intervene on the metabolic pathways related to the pathology being treated, blocking or stimulating the hormonal mechanisms that lead to hair loss and promoting hair regrowth.
Mention must be made here of the progenitor of the RestaX brand: RestaX 30 capsules + 30 softgels, which, thanks to the beta-sitosterol contained in the oil extract of Serenoa Repens, inhibits the binding between the 5-alpha reductase enzyme and testosterone, preventing the formation of dihydrotestosterone, which is responsible for premature hair loss in cases of male androgenetic alopecia. Other examples are products developed for female AGA, both fertile age and post-menopausal, which stimulate Estrone synthesis and thus lengthen the ANAGEN phase of the hair.
2. Importance of counteracting
inflammation
Wikenfarma was the first company in the trichological sector to combat trichological problems by trying to reduce scalp inflammation: in fact, according to recent studies, inflammation lies at the root of the pathogenesis of almost all trichological problems. This factor is often overlooked and untreated, making the action of active ingredients ineffective.
3. Assessment of the patient's psycho-emotional habitus
All the scientific evidence supporting the number one Italian company in trichology has highlighted a fundamental importance of the assessment of the psycho-emotional habitus of the trichological patient: often pathologies in trichology and dermatology are linked to components that go beyond the mere skin area but are also influenced by the emotional component of the patient.
Wanting to cite a successful example: with RestaX Effluvium, the first product (as well as the only one of its kind) was born specifically for the treatment of seasonal Telogen Effluvium and from Stress Telogen Effluvium, which also acts on the psycho-emotional component, which is closely connected with the manifestation and evolution of the same pathology.
4. New therapeutic approach
In addition to the scientific rationale and product specificity, Wikenfarma also stands out in the logic leading to the formulation of therapeutic strategies. Therapies in the trichological field are known to need a long time to exert their effect and, precisely for this reason, Wikenfarma has designed, in collaboration with opinion-leading physicians, a therapeutic modus divided into two basic phases: an attack phase and a maintenance phase.
This makes it possible to act consistently in those patients who present with pathology in the “acute” phase, so as to ensure certain results in the short term and lasting results over time.
Quali sono i piani futuri dell’azienda?
Wikenfarma is investing many resources in research and development to design new products specifically for categories of patients who today are forced to take standard nutraceuticals that are not targeted to their condition.
Continuing to grow and improve is essential to strive for excellence and to support a project in a concrete and conscious way. For this reason, Wikenfarma continues to support constant training to help create a united scientific community: in fact, thanks to the many events organized in the territory, it periodically provides insights for updating to the entire medical class, in collaboration with the greatest trichology experts nationwide. The goal is to spread a culture in which the patient is at the center of the mission of doctor and company, and in order to achieve this, it is essential to be able to provide tailor-made therapies that are sewn right on to the people who rely on Wikenfarma.
Condividi l'articolo sui tuoi social!
Stay up to date*, sign up for our Newsletter to receive every article on your email!
